Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Amazon.com invests in British Columbia to create more than 2,000 jobs » 07:47
05/07/21
05/07
07:47
05/07/21
07:47
AMZN

Amazon.com

$3,306.99 /

+35.18 (+1.08%)

Amazon announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital
04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

Recommendations
Provention Bio price target lowered to $19 from $25 at Cantor Fitzgerald » 07:01
05/07/21
05/07
07:01
05/07/21
07:01
PRVB

Provention Bio

$7.01 /

-0.23 (-3.18%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVB Provention Bio
$7.01 /

-0.23 (-3.18%)

PRVB Provention Bio
$7.01 /

-0.23 (-3.18%)

04/12/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
04/09/21 SVB Leerink
Provention Bio price target lowered to $16 from $26 at SVB Leerink
04/09/21 RBC Capital
Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
04/09/21 Cantor Fitzgerald
Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
PRVB Provention Bio
$7.01 /

-0.23 (-3.18%)

  • 14
    Jan
  • 18
    Jun
PRVB Provention Bio
$7.01 /

-0.23 (-3.18%)

PRVB Provention Bio
$7.01 /

-0.23 (-3.18%)

Hot Stocks
Pfizer, BioNTech initiate rolling submission of BLA for mRNA vaccine approval » 06:47
05/07/21
05/07
06:47
05/07/21
06:47
PFE

Pfizer

$39.19 /

-0.39 (-0.99%)

, BNTX

BioNTech

$168.03 /

-2.65 (-1.55%)

Pfizer (PFE) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

  • 23
    Jul
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

Periodicals
Amazon drivers encouraged to drive recklessly to meet quotas, Vice reports » 06:10
05/07/21
05/07
06:10
05/07/21
06:10
AMZN

Amazon.com

$3,306.99 /

+35.18 (+1.08%)

Some of Amazon's…

Some of Amazon's contracted delivery companies have been telling drivers to switch off its safety app, Vice's Lauren Kaori Gurley reports. The app, called Mentor, monitors their driving and assigns a safety score that ties into bonuses. Drivers said they're being told to turn it off so that they can speed through their delivery routes in order to hit Amazon's delivery targets, according to the report. Reference Link

ShowHide Related Items >><<
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital
04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

Hot Stocks
AstraZeneca Imfinzi demonstrates OS benefit in POSEIDON trial for NSCLC » 06:05
05/07/21
05/07
06:05
05/07/21
06:05
AZN

AstraZeneca

$53.51 /

-0.11 (-0.21%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

AZN AstraZeneca
$53.51 /

-0.11 (-0.21%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
05/07/21
05/07
04:55
05/07/21
04:55
PFE

Pfizer

$39.19 /

-0.39 (-0.99%)

, NVS

Novartis

$87.36 /

+0.81 (+0.94%)

, LLY

Eli Lilly

$193.83 /

+0.98 (+0.51%)

, GILD

Gilead

$66.54 /

+0.02 (+0.03%)

, SNY

Sanofi

$51.00 /

+0.41 (+0.81%)

, RHHBY

Roche

$41.27 /

+0.4 (+0.98%)

, EXAS

Exact Sciences

$107.95 /

-2.62 (-2.37%)

, NTRA

Natera

$96.39 /

-8.295 (-7.92%)

, SGEN

Seagen

$136.06 /

+0.87 (+0.64%)

ESMO Breast Cancer…

ESMO Breast Cancer Virtual Congress 2021 will be held on May 5-8. Webcast Link

ShowHide Related Items >><<
SNY Sanofi
$51.00 /

+0.41 (+0.81%)

SGEN Seagen
$136.06 /

+0.87 (+0.64%)

RHHBY Roche
$41.27 /

+0.4 (+0.98%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

NVS Novartis
$87.36 /

+0.81 (+0.94%)

NTRA Natera
$96.39 /

-8.295 (-7.92%)

LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

GILD Gilead
$66.54 /

+0.02 (+0.03%)

EXAS Exact Sciences
$107.95 /

-2.62 (-2.37%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
NVS Novartis
$87.36 /

+0.81 (+0.94%)

04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
GILD Gilead
$66.54 /

+0.02 (+0.03%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
SNY Sanofi
$51.00 /

+0.41 (+0.81%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
RHHBY Roche
$41.27 /

+0.4 (+0.98%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
EXAS Exact Sciences
$107.95 /

-2.62 (-2.37%)

05/05/21 Craig-Hallum
Exact Sciences price target lowered to $144 from $161 at Craig-Hallum
05/05/21 BTIG
Exact Sciences price target lowered to $155 from $175 at BTIG
02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
NTRA Natera
$96.39 /

-8.295 (-7.92%)

04/22/21 SVB Leerink
CMS coverage determination a positive for Natera, says SVB Leerink
03/10/21 Piper Sandler
Natera, Genentech start Phase 3 trial using Signatera, says Piper Sandler
02/26/21 Piper Sandler
Natera price target raised to $150 from $127 at Piper Sandler
01/27/21 Truist
Natera initiated with a Buy at Truist
SGEN Seagen
$136.06 /

+0.87 (+0.64%)

04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SNY Sanofi
$51.00 /

+0.41 (+0.81%)

SGEN Seagen
$136.06 /

+0.87 (+0.64%)

RHHBY Roche
$41.27 /

+0.4 (+0.98%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

NVS Novartis
$87.36 /

+0.81 (+0.94%)

NTRA Natera
$96.39 /

-8.295 (-7.92%)

LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

GILD Gilead
$66.54 /

+0.02 (+0.03%)

EXAS Exact Sciences
$107.95 /

-2.62 (-2.37%)

  • 11
    Sep
SNY Sanofi
$51.00 /

+0.41 (+0.81%)

RHHBY Roche
$41.27 /

+0.4 (+0.98%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

NVS Novartis
$87.36 /

+0.81 (+0.94%)

LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

GILD Gilead
$66.54 /

+0.02 (+0.03%)

SNY Sanofi
$51.00 /

+0.41 (+0.81%)

SGEN Seagen
$136.06 /

+0.87 (+0.64%)

RHHBY Roche
$41.27 /

+0.4 (+0.98%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

NVS Novartis
$87.36 /

+0.81 (+0.94%)

NTRA Natera
$96.39 /

-8.295 (-7.92%)

LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

GILD Gilead
$66.54 /

+0.02 (+0.03%)

EXAS Exact Sciences
$107.95 /

-2.62 (-2.37%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

LLY Eli Lilly
$193.83 /

+0.98 (+0.51%)

GILD Gilead
$66.54 /

+0.02 (+0.03%)

Yesterday
Periodicals
Amazon.com Prime Day in Canada halted due to COVID-19, Bloomberg says » 17:55
05/06/21
05/06
17:55
05/06/21
17:55
AMZN

Amazon.com

$3,306.99 /

+35.18 (+1.08%)

Amazon.com is putting its…

Amazon.com is putting its plans for its annual sale Prime Day in Canada on hold due to concerns about Covid-19, Bloomberg's Spencer Soper reports, citing an email to Amazon merchants. The pause won't affect Prime Day in the U.S., which is scheduled for an undisclosed day in June, the email said. Reference Link

ShowHide Related Items >><<
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital
04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

AMZN Amazon.com
$3,306.99 /

+35.18 (+1.08%)

On The Fly
Moderna, Pfizer slip despite stronger results as U.S. backs vaccine IP waiver » 14:30
05/06/21
05/06
14:30
05/06/21
14:30
MRNA

Moderna

$160.79 /

-1.89 (-1.16%)

, PFE

Pfizer

$38.91 /

-0.67 (-1.69%)

, BNTX

BioNTech

$170.34 /

-0.34 (-0.20%)

, AZN

AstraZeneca

$53.14 /

-0.48 (-0.90%)

, JNJ

Johnson & Johnson

$166.93 /

-0.16 (-0.10%)

, NVAX

Novavax

$175.00 /

+3.02 (+1.76%)

, VXRT

Vaxart

$6.88 /

-0.485 (-6.59%)

, CVAC

CureVac

$93.63 /

-7.39 (-7.32%)

While both Moderna (MRNA)…

ShowHide Related Items >><<
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.91 /

-0.67 (-1.69%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$175.00 /

+3.02 (+1.76%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
CVAC CureVac
$93.63 /

-7.39 (-7.32%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

Options
AstraZeneca put volume heavy and directionally bearish » 12:55
05/06/21
05/06
12:55
05/06/21
12:55
AZN

AstraZeneca

$53.13 /

-0.49 (-0.91%)

Bearish flow noted in…

Bearish flow noted in AstraZeneca with 4,133 puts trading, or 1.5x expected. Most active are May-21 47.5 puts and May-21 50 puts, with total volume in those strikes near 2,600 contracts. The Put/Call Ratio is 3.77, while ATM IV is up over 2 points on the day. Earnings are expected on July 29th.

ShowHide Related Items >><<
AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

AZN AstraZeneca
$53.13 /

-0.49 (-0.91%)

Periodicals
Germany's Merkel opposed to vaccine patent waivers, Bloomberg reports » 12:14
05/06/21
05/06
12:14
05/06/21
12:14
MRNA

Moderna

$156.69 /

-5.99 (-3.68%)

, PFE

Pfizer

$38.89 /

-0.69 (-1.74%)

, BNTX

BioNTech

$164.18 /

-6.5 (-3.81%)

, AZN

AstraZeneca

$53.16 /

-0.46 (-0.86%)

, JNJ

Johnson & Johnson

$166.87 /

-0.22 (-0.13%)

, NVAX

Novavax

$168.55 /

-3.43 (-1.99%)

, CVAC

CureVac

$93.30 /

-7.72 (-7.64%)

, VXRT

Vaxart

$6.60 /

-0.765 (-10.39%)

German Chancellor Angela…

German Chancellor Angela Merkel is opposed to a U.S. proposal to waive patent protections for COVID-19 vaccines, stating that such a plan would create "severe complications" for the production of vaccines, reported Bloomberg, citing a German government spokeswoman. Without a profit incentive, drugmakers might not move as aggressively to make vaccines, the industry has argued. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Vaxart (VXRT) and CureVac (CVAC). Reference Link

ShowHide Related Items >><<
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$168.55 /

-3.43 (-1.99%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
CVAC CureVac
$93.30 /

-7.72 (-7.64%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.